ARCHIVES

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

ImClone Protocol Generates More Questions Than Answers

March 8, 2002

CCOP Applications Total 110(At Least), Plus 25 from Research Bases; All 57 Survivors Try Again

November 21, 1986

Indoor Tanning Industry Funded Author Of NEJM Review On Vitamin D Deficiency.

April 18, 2008

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011